文献速递胃肠动力与功能性疾病消化内镜

经口内镜下肌切开术:前壁与后壁入路的随机单盲临床试验

Peroral endoscopic myotomy: anterior versus posterior approach: a randomized single-blinded clinical trial.
PubMed 文献 · Gastrointest Endosc · 2019-08-10

这项单盲、随机、非劣效性国际临床试验比较了经口内镜下肌切开术(POEM)前壁与后壁入路治疗贲门失弛缓症的疗效。

要点

  • POEM后壁入路1年临床成功率89%,前壁入路90%。
  • 技术成功率前壁组97.3% vs 后壁组100%(P=.23)。
  • 不良事件前壁组11% vs 后壁组9%(P=.703)。

核心结论

  • POEM后壁肌切开在疗效和安全性方面非劣于前壁肌切开,用于贲门失弛缓症患者。

研究设计与样本

  • 单盲、随机、非劣效性国际临床试验,纳入经高分辨率食管测压确诊的成人贲门失弛缓症患者,按1:1随机分配至前壁或后壁POEM组。

主要发现

  • 1年临床成功率(Eckardt评分<3)前壁组90% vs 后壁组89%。
  • 技术成功率前壁组71例(97.3%) vs 后壁组77例(100%)(P=.23)。
  • 术后中位住院时间两组均为2(1-3)天。
  • 不良事件前壁组8例(11%) vs 后壁组7例(9%)(P=.703)。
  • 食管酸暴露异常前壁组29/59例(49%) vs 后壁组25/60例(42%)(P=.67),GERD问卷评分组间无显著差异,两组所有36项简表健康调查指标的生活质量均改善且组间相似。

关键数值与推荐

  • 主要终点为1年临床成功率,定义为Eckardt评分<3。
  • 非劣效性设计比较前壁与后壁入路POEM的疗效。

临床怎么用

  • POEM可采用前壁或后壁入路,后壁入路在疗效和安全性上非劣于前壁入路。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Peroral endoscopic myotomy (POEM) has become the mainstay for the treatment of achalasia at many institutions around the world since its inception in 2008. POEM can be performed using either the anterior or posterior approach. The primary aim of this study was to compare the efficacy of the anterior and posterior approaches at 1 year after POEM. METHODS: This is a single-blinded, randomized, noninferiority international clinical trial. Eligible participants were adult patients with a confirmed diagnosis of achalasia via high-resolution esophageal manometry. Patients were randomly allocated with a 1:1 ratio to receive POEM with anterior or posterior approach. The primary aim was to compare the rate of clinical success (Eckardt score <3) of anterior and posterior approaches at 1 year. RESULTS: One hundred fifty patients were randomized to receive either anterior (n = 73) or posterior (n = 77) POEM. One hundred forty-eight patients received the POEM treatment, and 138 patients completed the 1-year follow-up and were included in the primary efficacy analysis. Technical success was achieved in 71 patients (97.3%) in the anterior group versus 77 patients (100%) in the posterior group (P = .23). The median (interquartile range) length of hospital stay after the procedure was 2 (1-3) days for both groups. Adverse events occurred in 15 patients (10%), 8 patients (11%) in the anterior group and 7 patients (9%) in the posterior group (P = .703). Clinical success was achieved in 90% of patients in the anterior group and 89% of patients in the posterior group. Abnormal esophageal acid exposure was detected in 29 of 59 patients (49%) and 25 of 60 patients (42%) in the anterior and posterior groups, respectively (P = .67). GERD questionnaire scores were also not significantly different between the study groups. In both groups, quality of life improved after POEM for all 36-Item Short-Form Health Survey measures and was similar between both groups. CONCLUSIONS: Posterior myotomy during POEM was not inferior to anterior myotomy in terms of efficacy and safety in the treatment of patients with achalasia. (Clinical trial registration number: NCT02454335.).

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Khashab MA, Sanaei O, Rivory J, et al. Peroral endoscopic myotomy: anterior versus posterior approach: a randomized single-blinded clinical trial. Gastrointest Endosc. 2019. PMID: 31408652. doi:10.1016/j.gie.2019.07.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。